<?xml version="1.0" encoding="UTF-8"?>
<p>SbD of medical products made by materials processing is built on the principles of the US FDA regulatory guidelines of 2003 and adopted by EMA in 2003 as described by Brenderlberger 2003 [
 <xref rid="B112-materials-13-04532" ref-type="bibr">112</xref>]. These have been further adapted for ATMPs involving NBMs within this RMF paper and described in 
 <xref ref-type="fig" rid="materials-13-04532-f003">Figure 3</xref> below. 
</p>
